© 2026 Improve the News Foundation.
All rights reserved.
Version 6.20.2
Weight‑loss injections like Ozempic and Wegovy can produce quick results, but most users regain nearly all lost weight within a year, often faster than people following diet and exercise programs. The drugs create dependence without building lasting habits, and prolonged use can carry health risks, making lifelong reliance unrealistic and unsafe. Relying on expensive, short-term interventions while ignoring behavioral change sets millions up for failure and wastes resources on a fleeting fix.
GLP‑1 drugs like Ozempic and Wegovy can be a powerful tool for adults with obesity when combined with diet, exercise and professional support. They can produce up to 20% weight loss and reduce risks of heart attack, stroke and diabetes by around 20% over three years. Although sometimes seen as a "quick fix," these therapies offer millions a medically validated option to supplement lifestyle changes in managing a chronic condition that causes 3.7 million deaths globally each year.